Zai Lab (ZLAB) Cash from Financing Activities (2018 - 2026)

Zai Lab (ZLAB) posted Cash from Financing Activities of $5.6 million for Q1 2026, up 1396.05% sequentially from -$430000.0 in Q4 2025, and down 87.08% YoY from $43.1 million in Q1 2025.

Zai Lab (ZLAB) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Zai Lab has reported Cash from Financing Activities for 9 years, with the latest figure at $5.6 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 87.08% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.8 million (down 89.93% YoY) and the FY2025 annual result came in at $72.4 million, down 79.32% from the prior year.
  • Cash from Financing Activities advanced to $5.6 million in Q1 2026 per ZLAB's latest filing, from -$430000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $237.8 million in Q4 2024 and troughed at -$3.9 million in Q1 2023.
  • A 5-year average of $24.7 million and a median of $709000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities plunged 1606.2% in 2023, then jumped 60411.96% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$199000.0 in 2022, then surged by 297.49% to $393000.0 in 2023, then surged by 60411.96% to $237.8 million in 2024, then tumbled by 100.18% to -$430000.0 in 2025, then jumped by 1396.05% to $5.6 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $5.6 million, -$430000.0, and $20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 18.71 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.71 Mn
Jun 30, 2026 18.71 Mn
Mar 31, 2026 5.57 Mn
Mar 31, 2026 5.57 Mn
Dec 31, 2025 -430,000.00
Dec 31, 2025 -430,000.00
Sep 30, 2025 20.79 Mn
Sep 30, 2025 20.79 Mn
Jun 30, 2025 8.85 Mn
Jun 30, 2025 8.85 Mn
Mar 31, 2025 43.14 Mn
Mar 31, 2025 43.14 Mn
Dec 31, 2024 237.81 Mn
Dec 31, 2024 237.81 Mn
Sep 30, 2024 42.21 Mn
Sep 30, 2024 42.21 Mn
Jun 30, 2024 22.32 Mn
Jun 30, 2024 22.32 Mn
Mar 31, 2024 47.55 Mn
Mar 31, 2024 47.55 Mn